About GHK-Cu Telehealth: Independent Copper Peptide Research Digest
About This Site
GHK-Cu Telehealth is an independent editorial project that publishes summaries of the peer-reviewed research literature on GHK-Cu — the copper-binding tripeptide glycyl-L-histidyl-L-lysine. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.
GHK-Cu has a substantial research record covering wound healing, collagen synthesis, hair follicle stimulation, gene expression modulation, pulmonary protection, and neuroprotection in aging models. The published literature spans five decades and more than twenty-five primary studies. This site exists to make that literature accessible in plain language, with every claim cited to its source.
Our Editorial Approach
We apply a consistent standard across every page:
- Every quantitative claim is tied to a numbered citation in the references list.
- Findings are described in third person, attributed to the study and species in which they were measured.
- When human data exist (topical wound healing, photoaging trials, hair growth RCTs), we say so explicitly.
- When only preclinical data exist (injectable rodent models, in vitro gene expression), we say so explicitly.
- We do not describe injectable dosing as if it were a recommendation. "Studied at X mg/kg in mice" is a research finding, not advice.
- We do not link to product vendors, compound sources, or purchasing pages.
The result is a research digest that is honest about what is known, honest about what is not, and readable without a biochemistry background.
GHK-Cu Telehealth and Remote Consultation
The name 'GHK-Cu Telehealth' is an editorial position — it places this site in the emerging conversation around digital health literacy for research peptides. It is not a description of services offered.
This site does not offer telehealth consultations. There is no patient intake form, no prescriber profile, no booking widget, and no clinical staff. The 'telehealth' framing reflects where the GHK-Cu research conversation is going — toward digital, plain-language, well-cited health information that readers can bring to their own healthcare conversations — not what this site currently provides.
If you are considering GHK-Cu in any clinical context, a licensed practitioner who has reviewed the peer-reviewed literature is the appropriate source of guidance.
Editorial Disclaimer
The content on this site is editorial commentary on publicly available peer-reviewed research. It is not medical advice, clinical guidance, or a substitute for consultation with a qualified healthcare professional. Nothing on this site constitutes a recommendation to use, purchase, or administer GHK-Cu or any related compound.
GHK-Cu has no FDA-approved therapeutic indication for injectable or systemic use. Topical cosmetic formulations are broadly used; injectable preparations used outside formal research protocols are not FDA-approved drug formulations.
This site contains no outbound links to product vendors, supplement retailers, or compound sources.